Zynerba Pharmaceuticals' Series A Round

Zynerba Pharmaceuticals raised a round of funding on October 15, 2014.

Zynerba Pharmaceuticals is a clinical-stage pharmaceutical company that is dedicated to the development of innovative transdermal synthetic cannabinoid treatments for patients with high unmet medical …

Articles about Zynerba Pharmaceuticals' Series A Round: